help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eielson, C.
Right arrow Articles by Insogna, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eielson, C.
Right arrow Articles by Insogna, K.

Endocrinology, Vol 135, 1639-1644, Copyright © 1994 by Endocrine Society


ARTICLES

Estrogen modulates parathyroid hormone-induced fibronectin production in human and rat osteoblast-like cells

C Eielson, D Kaplan, MA Mitnick, I Paliwal and K Insogna
Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8010.

Fibronectin (FN) is an important constituent of the extracellular matrix in bone. Its hormonal regulation in this tissue has not been extensively studied. We, therefore, examined the effects of PTH, estrogen, and transforming growth factor beta on the production of FN by human and rat osteoblast-like cells. Confluent cells were stabilized for 48 h under estrogen-replete (10(-9) M 17 beta-estradiol) conditions and then continued under these same conditions or withdrawn from estrogen for varying periods of time. PTH over the range 10(-11)-(10(- 8) M caused a dose-dependent increase in FN production [P < 0.001 by analysis of variance (ANOVA)] such that at the highest dose, FN production was increased 11-fold. Estrogen withdrawal for 96 h caused a significant diminution in PTH-induced FN production (P < 0.005 by two- way ANOVA). Estrogen withdrawal over the of period 48-144 h caused a progressive diminution in PTH-induced FN production such that differences in mean values for estrogen-replete vs. deficient conditions were greater at 144 than 48 h (P < 0.05). The estrogen effect was titratable over the range 10(-11)-10(-9) M, and the inactive congener 17 alpha-estradiol failed to prevent the inhibitory effect of estrogen withdrawal on PTH-induced FN production. Interestingly, estrogen withdrawal had absolutely no effect on transforming growth factor-beta-induced FN production. Northern analysis demonstrated no effect of PTH on steady-state FN messenger RNA levels in Saos-2 cells under either estrogen-replete or estrogen-deficient conditions, suggesting that PTH effects an increase in FN production via a posttranscriptional mechanism in these cells. We conclude that PTH stimulates FN production in human and rat osteoblast-like cells, and under estrogen-deficient conditions this effect is significantly diminished. The modulatory effect of estrogen is not a universal phenomenon because transforming growth factor-beta-induced FN production is unaffected by estrogen withdrawal.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G.-Q. Yao, J.-J. Wu, S. Ovadia, N. Troiano, B. H. Sun, and K. Insogna
Targeted overexpression of the two colony-stimulating factor-1 isoforms in osteoblasts differentially affects bone loss in ovariectomized mice
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E714 - E720.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. A. Nakchbandi, R. Lang, B. Kinder, and K. L. Insogna
The Role of the Receptor Activator of Nuclear Factor-{kappa}B Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 967 - 973.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. H. Straub
The Complex Role of Estrogens in Inflammation
Endocr. Rev., August 1, 2007; 28(5): 521 - 574.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. M. Boyden, J. Mao, J. Belsky, L. Mitzner, A. Farhi, M. A. Mitnick, D. Wu, K. Insogna, and R. P. Lifton
High Bone Density Due to a Mutation in LDL-Receptor-Related Protein 5
N. Engl. J. Med., May 16, 2002; 346(20): 1513 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. A. Nowak, F. Haimovici, J. D. Biggers, and G. T. Erbach
Transforming Growth Factor-ß Stimulates Mouse Blastocyst Outgrowth through a Mechanism Involving Parathyroid Hormone-Related Protein
Biol Reprod, January 1, 1999; 60(1): 85 - 93.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. h. Sun, M. Mitnick, C. Eielson, G. Q. Yao, I. Paliwal, and K. Insogna
Parathyroid Hormone Increases Circulating Levels of Fibronectin in Vivo: Modulating Effect of Ovariectomy
Endocrinology, September 1, 1997; 138(9): 3918 - 3924.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Moursi, R. Globus, and C. Damsky
Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro
J. Cell Sci., January 9, 1997; 110(18): 2187 - 2196.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
A. Moursi, C. Damsky, J Lull, D Zimmerman, S. Doty, S Aota, and R. Globus
Fibronectin regulates calvarial osteoblast differentiation
J. Cell Sci., January 6, 1996; 109(6): 1369 - 1380.
[Abstract] [PDF]


Home page
DevelopmentHome page
J. Wysolmerski, J. McCaughern-Carucci, A. Daifotis, A. Broadus, and W. Philbrick
Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development
Development, January 11, 1995; 121(11): 3539 - 3547.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society